Advertisement

Ads Placeholder
Loading...

Inventiva S.A.

IVEVFPNK
Healthcare
Biotechnology
$5.50
$0.00(0.00%)
U.S. Market opens in 4h 57m

Inventiva S.A. Fundamental Analysis

Inventiva S.A. (IVEVF) shows weak financial fundamentals with a PE ratio of -8.45, profit margin of -79.01%, and ROE of 6.13%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.21
Current Ratio2.96

Areas of Concern

ROE6.13%
Operating Margin-29.44%
Cash Position4.19%
We analyze IVEVF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -7282.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-7282.3/100

We analyze IVEVF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVEVF struggles to generate sufficient returns from assets.

ROA > 10%
-1.98%

Valuation Score

Excellent

IVEVF trades at attractive valuation levels.

PE < 25
-8.45
PEG Ratio < 2
-0.21

Growth Score

Weak

IVEVF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IVEVF maintains a strong and stable balance sheet.

Debt/Equity < 1
-6.41
Current Ratio > 1
2.96

Profitability Score

Weak

IVEVF struggles to sustain strong margins.

ROE > 15%
6.13%
Net Margin ≥ 15%
-79.01%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVEVF Expensive or Cheap?

P/E Ratio

IVEVF trades at -8.45 times earnings. This suggests potential undervaluation.

-8.45

PEG Ratio

When adjusting for growth, IVEVF's PEG of -0.21 indicates potential undervaluation.

-0.21

Price to Book

The market values Inventiva S.A. at -336.00 times its book value. This may indicate undervaluation.

-336.00

EV/EBITDA

Enterprise value stands at -5.45 times EBITDA. This is generally considered low.

-5.45

How Well Does IVEVF Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-79.01 as profit after all expenses.

-79.01%

Operating Margin

Core operations generate -29.44 in profit for every $100 in revenue, before interest and taxes.

-29.44%

ROE

Management delivers $6.13 in profit for every $100 of shareholder equity.

6.13%

ROA

Inventiva S.A. generates $-1.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.98%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-30.48M, signaling weaker underlying cash strength.

$-30.48M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-30.57M, restricting financial flexibility.

$-30.57M

FCF Per Share

Each share generates $-0.22 in free cash annually.

$-0.22

FCF Yield

IVEVF converts -21.44% of its market value into free cash.

-21.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.45

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.21

vs 25 benchmark

P/B Ratio

Price to book value ratio

-336.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

145.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-6.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

6.13

vs 25 benchmark

ROA

Return on assets percentage

-1.98

vs 25 benchmark

ROCE

Return on capital employed

-1.09

vs 25 benchmark

How IVEVF Stacks Against Its Sector Peers

MetricIVEVF ValueSector AveragePerformance
P/E Ratio-8.4528.23 Better (Cheaper)
ROE612.82%737.00% Neutral
Net Margin-7901.05%-46175.00% (disorted) Weak
Debt/Equity-6.410.35 Strong (Low Leverage)
Current Ratio2.964.10 Strong Liquidity
ROA-197.85%-17785.00% (disorted) Weak

IVEVF outperforms its industry in 3 out of 6 key metrics, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ